Investigators sought to determine whether weight-based dosing of pembrolizumab could produce outcomes similar to standard fixed dosing for patients with NSCLC.

PD-1 checkpoint inhibitors related immune-mediated hepatitis in colon cancer: A systematic review and meta-analysis. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...

The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight ...

Data from the phase 3b STEP UP trial demonstrate that the 7.2 mg semaglutide dose provides superior weight reduction compared with the 2.4 mg dose and placebo.

A patient who developed atrial fibrillation resulting from the failure to adjust their levothyroxine dose after rapid, significant weight loss while on the antiobesity drug tirzepatide (Zepbound) ...

Add Yahoo as a preferred source to see more of our stories on Google. One size doesn't fit all—this statement holds true for bodies in general, pant sizes and weight loss journeys. It is also the case ...

Many prescription medications are dispensed in weight-based single-dose vials containing standard amounts of drugs that exceeds required dosages for the average patient, leading to billions of dollars ...